Global biochips market consists of technology used for detecting and identifying biological molecules from pathogens and genes to proteins and DNA sequences. Biochips are used in drug discovery, disease diagnosis, and food safety, among others.  Increasing R&D efforts and funding from governments and private organizations for developing innovative biosensor technologies can drive the market growth. Advancements in fields of molecular biology and rise of precision medicine have accelerated the adoption of biochips across industries. Enhancements in biochip design and manufacturing processes can offer  lucrative growth opportunities in the near future.

Market Dynamics:

Global biochips market growth is driven by rising prevalence of diseases like cancer and focus on early diagnosis. Growing investments in biotechnology and life science research also boosts demand for biochips to detect biomolecular interactions at microscopic levels. However, high costs associated with biochip development and strict regulatory norms can delay product approvals. Lack of skilled professionals can hamper its wider adoption. Untapped opportunities in developing nations present lucrative prospects. Emergence of microarray and microfluidic technology have improved detection capacities of biochips, thus, expanding application areas from healthcare to environmental monitoring and food safety testing.

Key features of the study:

This report provides in-depth analysis of the global biochips market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year

- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

- It profiles key players in the global biochips market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

- Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific Inc., Agilent Technologies, Bio-Rad Laboratories Inc., PerkinElmer Inc., Fluidigm Corporation, and GE Healthcare

- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

- Global biochips market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biochips market

Detailed Segmentation-

• By Product Type
  
  • DNA Chips
    
    • Cancer Diagnosis and Treatment
    • Gene Expression
    • SNP Genotyping
    • Genomics
    • Drug Discovery
    • Agricultural Biotechnology
    • Others
  • Protein Chips
    
    • Proteomics
    • Expression Profiling
    • Diagnostics
    • HTS
    • Others
  • Lab-on-chip
    
    • IVD & POC
    • Others
  • Tissue Arrays
  • Cell Arrays  
• By End User
  
  • Biotechnology and Pharmaceutical Companies
  • Academic & Research Institutes
  • Hospitals and Diagnostic Centers
  • Others
• By Region           
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Fluidigm Corporation
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Standard BioTools
  • GE Healthcare
  • Hoffmann-La Roche AG
  • QIAGEN
  • Randox Laboratories Ltd
  • LI-COR, Inc.
  • Merck KGaA
  • Becton, Dickinson and Company
  • Arrayit Corporation
  • Nanostring Technologies, Inc.
  • GnuBio, Inc.